Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("REISER, Markus")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

First-line therapy with daily versus thrice-weekly interferon alfa-2b plus ribavirin for chronic hepatitis CREISER, Markus; BUGGISCH, Peter; GROSSMANN, Johannes et al.European journal of gastroenterology & hepatology. 2003, Vol 15, Num 12, pp 1299-1304, issn 0954-691X, 6 p.Article

The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the ss-catenin signaling pathwayMUNDING, Johanna; ZIEBARTH, Wibke; POX, Christian P et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 3, pp 637-643, issn 0143-3334, 7 p.Article

Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population LevelNEUMANN-HAEFELIN, Christoph; FRICK, David N; VIAZOV, Sergei et al.Journal of virology. 2008, Vol 82, Num 7, pp 3438-3451, issn 0022-538X, 14 p.Article

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis CREISER, Markus; HINRICHSEN, Holger; BENHAMOU, Yves et al.Hepatology (Baltimore, Md.). 2005, Vol 41, Num 4, pp 832-835, issn 0270-9139, 4 p.Article

Colonic cancer and polypsSCHULMANN, Karsten; REISER, Markus; SCHMIEGEL, Wolff et al.Baillière's best practice & research. Clinical gastroenterology. 2002, Vol 16, Num 1, pp 91-114, issn 1521-6918Article

Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatmentERHARDT, Andreas; DETERDING, Katja; FUCHS, Michael et al.Antiviral therapy (London). 2009, Vol 14, Num 1, pp 23-32, issn 1359-6535, 10 p.Article

Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromesSCHULMANN, Karsten; HOLLERBACH, Stephan; KRAUS, Katja et al.The American journal of gastroenterology. 2005, Vol 100, Num 1, pp 27-37, issn 0002-9270, 11 p.Article

Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapyLAUER, Georg M; LUCAS, Michaela; REISER, Markus et al.Journal of virology. 2005, Vol 79, Num 20, pp 12979-12988, issn 0022-538X, 10 p.Article

Degree of Cross-Genotype Reactivity of Hepatitis C Virus-Specific CD8+ T Cells Directed Against NS3GIUGLIANO, Silvia; OEZKAN, Filiz; BEDREJOWSKI, Mathias et al.Hepatology (Baltimore, Md.). 2009, Vol 50, Num 3, pp 707-716, issn 0270-9139, 10 p.Article

Detection of Novel Biomarkers of Liver Cirrhosis by Proteomic AnalysisMÖLLEKEN, Christian; SITEK, Barbara; TORNØE, Ida et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 4, pp 1257-1266, issn 0270-9139, 10 p.Article

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C : A randomized open-label pilot studyCORNBERG, Markus; HADEM, Johannes; HERRMANN, Eva et al.Journal of hepatology. 2006, Vol 44, Num 2, pp 291-301, issn 0168-8278, 11 p.Article

Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061HERRMANN, Eva; ZEUZEM, Stefan; STEINMANN, Gerhard G et al.Antiviral therapy (London). 2006, Vol 11, Num 3, pp 371-376, issn 1359-6535, 6 p.Article

  • Page / 1